Blue light hope for postpartum depression

NCT ID NCT06246214

Recruiting now Symptom relief Sponsor: Hospital de Clinicas de Porto Alegre Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special blue light device can improve mood in women who are 4-6 weeks postpartum and have depression or anxiety. Half of the 50 depressed participants will use the blue light, the other half a dim placebo light. The researchers will also track sleep and body rhythms to understand how light affects mental health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Blue light therapy device
What this could lead to: If it works, this could offer a simple, drug-free way to reduce depression and anxiety in new mothers.
What could go wrong: This is a small, early-stage trial with only 50 women receiving the active treatment. The placebo device also emits light, so the real benefit may be small or unclear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY STATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY STATE DEPRESSION, POSTPARTUM

Contacts and locations

Locations

Hospital de Clínicas de Porto Alegre
RECRUITING

Porto Alegre, Rio Grande do Sul, 90410-000, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.